Evidence map›Paper›PMID 22193219›Full record

ReviewRheumatology international2012

Diversity, value and limitations of the journal impact factor and alternative metrics.

Lutz Bornmann, Werner Marx, Armen Yuri Gasparyan, George D Kitas

Abstract readReview
PubMed Publisher
In one paragraph

Review in Rheumatology international, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Author Self-Citation in the Turkish Otorhinolaryngology Literature.Turkish archives of otorhinolaryngology · 2021
    Article
  13. Review
  14. Article
  15. Article
  16. Evaluating Journal Impact Factor: a systematic survey of the pros and cons, and overview of alternative measures.The journal of venomous animals and toxins including tropical diseases · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lutz BornmannMax Planck Society, Administrative Headquarters, Munich, Germany.
Werner Marx
Armen Yuri Gasparyan
George D Kitas

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The highly popular journal impact factor (JIF) is an average measure of citations within 1 year after the publication of a journal as a whole within the two preceding years. It is widely used as a proxy of a journal's quality and scientific prestige. This article discusses misuses of JIF to assess impact of separate journal articles and the effect of several manuscript versions on JIF. It also presents some newer alternative journal metrics such as SCImago Journal Rank and the h-index and analyses examples of their application in several subject categories.

Indexed as

Journal Impact FactorPeriodicals as TopicRheumatology

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.